A new study, led by RCSI researchers, has found that patients receiving methadone treatment are most at risk of overdosing in the month following the end of methadone treatment and during the first four weeks of treatment.
8 hours ago
0
0
A real-world study of over 600,000 adult participants without a history of depression has found that the stop-smoking medication varenicline (marketed as Chantix in the US and Champix elsewhere in the world) does not appear ...
20 hours ago
0
1
Drug discovery software at Southwest Research Institute is expanding the capacity to virtually screen drug compounds for possible treatment of coronavirus and other infectious diseases.
Feb 19, 2020
0
3
(HealthDay)—The antihypertensive medication amlodipine is associated with a lower risk for gout compared with other antihypertensive agents, according to a study published online Jan. 20 in the Journal of Hypertension.
Feb 18, 2020
0
3
Doctors prescribe more branded medications after marketing visits by the makers of those drugs, new research co-authored by a Cornell University economist confirms.
Feb 18, 2020
0
1
Researchers from the University of Sydney have conducted the first global review of herbal medicines for weight loss in 19 years, finding insufficient evidence to recommend any current treatments.
Feb 17, 2020
1
75
The most recent guidelines for primary prevention recommend aspirin use for individuals ages 40 to 70 years who are at higher risk of a first cardiovascular event, but not for those over 70. Yet, people over 70 are at increasingly ...
Feb 17, 2020
0
5
More than two-thirds of Americans take dietary supplements. The vast majority of consumers—84% – are confident the products are safe and effective.
Feb 17, 2020
0
7
A devastating shortage of the pediatric cancer drug vincristine that began late last summer has forced pediatric oncologists across the country to make heart-wrenching decisions about allocation and treatment.
Feb 17, 2020
0
4
A clinical trial of the weight-loss drug Belviq (lorcaserin) shows an association with an increased risk of cancer, and the U.S. Food and Drug Administration is requesting that its maker withdraw the drug from the U.S. market.
Feb 14, 2020
0
3
